IL18 and Alzheimer disease: In the absence of IL-12, IL-18 has been shown to modulate the Th2 pathway, inducing expression of IL-4, IL-13, and IgE by basophils (43) The downstream effect of these expressed factors has been linked to AD pathogenesis.